Does androgen deprivation therapy protect against severe complications from COVID-19?

Affiliations

¹ Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
² Department of Population Health and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.
³ Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. Electronic address: william.oh@mssm.edu.

Comment

V G Patel et al. Ann Oncol. 2020 Oct.

. 2020 Oct;31(10):1419-1420.

doi: 10.1016/j.annonc.2020.06.023. Epub 2020 Jul 9.

¹ Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
² Department of Population Health and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.
³ Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. Electronic address: william.oh@mssm.edu.

No abstract available

Comment on

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, Carbone GM, Cavalli A, Pagano F, Ragazzi E, Prayer-Galetti T, Alimonti A. Montopoli M, et al. Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6. Ann Oncol. 2020. PMID: 32387456 Free PMC article.

1. Hoffmann M., Kleine-Weber H., Schroeder S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e8. - PMC - PubMed
1. Zhou P., Yang X.L., Wang X.G. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. - PMC - PubMed
1. Iwata-Yoshikawa N., Okamura T., Shimizu Y., Hasegawa H., Takeda M., Nagata N. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol. 2019;93:e01815–e01818. - PMC - PubMed
1. Lin B., Ferguson C., White J.T. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 1999;59:4180–4184. - PubMed
1. Montopoli M., Zumerle S., Vettor R. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) Ann Oncol. 2020;31(8):1040–1045. - PMC - PubMed